Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(3.0%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GenScript Biotech Corporation(47.99%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hillhouse Investment Management, Ltd.(3.6%),HHLR Advisors, Ltd.(3.6%)
Legend Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(5.9%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.040%),Abigail P. Johnson(7.040%)
Legend Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.8%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-FMR LLC(9.999%),Abigail P. Johnson(9.999%)
Legend Biotech | D: Filing D
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Hillhouse Investment Management, Ltd.(5.9%),HHLR Advisors, Ltd.(5.9%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Fangliang Zhang(0.32%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-GenScript Corporation(0.12%),AquaPoint L.P.(0.00%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-GenScript Biotech Corporation(52.12%)
Legend Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Abigail P. Johnson(9.227%),FMR LLC(9.227%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GenScript Biotech Corporation(57.1%)
Legend Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hillhouse Investment Management, Ltd.(10.6%),HHLR Advisors, Ltd.(10.6%)
Legend Biotech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Legend Biotech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Legend Biotech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Legend Biotech | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Legend Biotech | D: Filing D
No Data